Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults
Clinical trial NCT03880474 · TERMINATED
Trial details
- NCT number
- NCT03880474
- Sponsor
- Barinthus Biotherapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-18
- Primary completion
- 2019-10-15
- Enrollment
- 2364
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.